Commentary
Are there any differences in genomic characterization of non-small cell lung cancer between African Americans and Whites?
Abstract
Lung cancer is the most common cancer and the leading cause of cancer-related deaths worldwide; in 2012, around 1.82 million new cases were diagnosed and
1.59 million patients died of the disease globally (1). It remains essentially incurable despite recent advances in conventional treatment, including surgical resection, radiotherapy, and drug therapy. African Americans have especially been reported to have poorer prognosis when compared with Whites (2-4).
1.59 million patients died of the disease globally (1). It remains essentially incurable despite recent advances in conventional treatment, including surgical resection, radiotherapy, and drug therapy. African Americans have especially been reported to have poorer prognosis when compared with Whites (2-4).
